Frontiers in the Treatment of Diabetes
10.3870/j.issn.1004-0781.2016.07.001
- VernacularTitle:糖尿病的前沿治疗药物与治疗方案
- Author:
Feng GAO
;
Liping LI
;
Huan LI
;
Jinlan PENG
- Publication Type:Journal Article
- Keywords:
DPP4 inhibitors;
GLP-1 receptor agonist;
SGLT2 inhibitors;
Amylin analogues;
Dopamine receptor agonist;
Diabetes mellitus;
Bariatric surgery;
Pancreatic stem cell transplantation
- From:
Herald of Medicine
2016;35(7):679-687
- CountryChina
- Language:Chinese
-
Abstract:
In recent years,the prevalence of diabetes is increasing year by year with the improvement of people's living standard.The traditional oral anti-hyperglycemic drugs as well as insulin injection therapy can not block the progress of the disease course.The deterioration of glycaemic control results in various acute and chronic complications which seriously affect patients' health and bring huge economic burden.The researchers have been seeking new therapeutic regimens to improve or even reverse diabetes process.This paper focuses on the following novel treatment options such as GLP-1 receptor agonist,DPP4 inhibitors, fixed-dose combination,SGLT2 inhibitors,amylin analogues,dopamine receptor agonist,bile acid sequestrant,bariatric surgery and pancreatic stem cell transplantation.
